Biocodex is a finished-dose manufacturer based in France. It appears in 299 regulatory filings across 28 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, ANSM (FR) and FDA (GH). Its GMP standing is certified by ANSM (FR), MFDS (Korea) and NAFDAC (NG), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 17 June 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Beauvais, United Arab Emirates | Not on file |
| BEAUVAIS, France | Not on file |
| France, France | 3003346516 |
| NOUACEUR, Morocco | Not on file |
| avenue Blaise Pascal 60 Beauvais France, Nigeria | Not on file |
| Montijo, Portugal | Not on file |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 47 | 1 |
| ANSM (FR) | 28 | 25 |
| FDA (GH) | 26 | None |
| AIFA (IT) | 23 | None |
| FAMHP (BE) | 22 | None |
| URPL (PL) | 18 | None |
| MFDS (Korea) | None | 2 |
| NAFDAC (NG) | None | 2 |
| ANVISA (Brazil) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $543.1M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Biocodex comes back tiered against every other supplier able to file there.
Start for free